Can Stem Cell Therapy Slow GA? - Top-Institutions - MDSpire

Can Stem Cell Therapy Slow GA?

Phase 1b data for ASP7317, presented at ASRS, showed a favorable safety profile, encouraging visual acuity findings, and stabilization of geographic atrophy in patients with advanced disease.

  • By

  • VIVIENNE HAU, MD, PHD

  • July 15, 2026

  • 3 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    National Eye Institute, National Institutes of Health
    National Eye Institute, National Institutes of Health

    Bethesda, Maryland

    Key Differentiators

    • Ophthalmology
    • Stem Cell Research

  • #2

    USC Roski Eye Institute, Keck School of Medicine of USC
    USC Roski Eye Institute, Keck School of Medicine of USC

    Los Angeles, California

    Key Differentiators

    • Ophthalmology
    • Stem Cell Research

  • #3

    Cincinnati Eye Institute
    Cincinnati Eye Institute

    Cincinnati, Ohio

    Key Differentiators

    • Ophthalmology

  • #4

    University of Cincinnati School of Medicine
    University of Cincinnati School of Medicine

    Cincinnati, Ohio

    Key Differentiators

    • Ophthalmology

  • #5

    University of Pittsburgh Medical Center Vision Institute
    University of Pittsburgh Medical Center Vision Institute

    Pittsburgh, Pennsylvania

    Key Differentiators

    • Ophthalmology

Original Source(s)

Can Stem Cell Therapy Slow GA?

  • by VIVIENNE HAU, MD, PHD

  • July 15, 2026

Related Content

Elevated GDF15 in ocular fluids of patients with proliferative diabetic retinopathy

Optical coherence tomography acquisition efficiency: comparison of Heidelberg spectralis OCT2 module & Zeiss Cirrus HD-OCT model 6000

Neuroprotection: Retina's Next Frontier?

At OIS Retina in Montreal, Riad Sherif, MD, discussed Oculis’s optic neuritis program and why neuroprotection may represent the next frontier in retinal therapeutics.